Effect of metformin on exercise capacity in metabolic syndrome. (November 2017)

• Record Type: Journal Article
• Authors: Paul, Abi Albon; Dkhar, Steven Aibor; Kamalanathan, Sadishkumar; Thabah, Molly Mary; George, Melvin; Chandrasekaran, Indumathi; Gunaseelan, Vikneswaran; Selvarajan, Sandhiya
• Is Part Of: Diabetes & metabolic syndrome. Volume 11(2017)Supplement 1
• Page Start: S403
• Page End: S406
• Publication Date: 2017-11
• Subjects: Exercise capacity -- Metabolic syndrome -- Metformin; Diabetes -- Periodicals; Metabolism -- Disorders -- Periodicals; Diabetes Mellitus -- Periodicals; Metabolic Diseases -- Periodicals; Diabète -- Périodiques; Métabolisme, Troubles du -- Périodiques; Endocrinologie -- Périodiques; Diabète -- Physiopathologie -- Périodiques; Diabetes; Metabolism -- Disorders; Electronic journals; Periodicals; 616.462
• DOI: 10.1016/j.dsx.2017.03.025
• Languages: English
• ISSNs: 1871-4021

Abstract

Abstract: Objective: Metabolic syndrome is a constellation of risk factors with increased predilection towards occurrence of cardiovascular diseases. Currently physical exercise and management with metformin are the prevailing treatment modalities for metabolic syndrome. Patients with metabolic syndrome have been found to have reduced exercise capacity over a period of time. Likewise metformin has been shown to decrease exercise capacity among healthy volunteers. Hence this study aims to evaluate the effect of metformin on the exercise capacity of patients with metabolic syndrome. Design: Prospective study with 6 weeks follow up. Methods: Newly diagnosed patients with metabolic syndrome and to be started on Table Metformin 500 mg twice a day were recruited for the study after obtaining written informed consent. Cardiopulmonary Exercise Testing (CPET) was done at baseline before the subjects were started on metformin and after 6 weeks of treatment using cardiopulmonary exercise testing apparatus (ZAN600). Results: Fifteen treatment naïve patients with metabolic syndrome completed six weeks of therapy with metformin. In these patients oxygen uptake [VO2] showed statistically significant decrease from 1.10 ± 0.44 at baseline to 0.9 ± 0.39 (l/min) after six weeks of treatment with metformin [mean difference of −0.20 (−0.31 to −0.09); P = 0.001]. Similarly oxygen uptake/kg body weight [VO2/Kg] showed a significant decrease from 14.10 ± 4.73 to 11.44 ± 3.81 (ml kg −1 min −1 ) at the end of six weeks of treatment [mean difference of −2.66 (−4.06 to −1.26); P = 0.001]. Conclusion: Six weeks of treatment with metformin significantly decreases exercise capacity in newly diagnosed patients with metabolic syndrome.